| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |